JNJ-16-IDO

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameJNJ-16-IDO
Drug Alias NameIDO1 modulator (Janssen/Rega Institute for Medical Research/National Autonomous University of Mexico)JNJ-16-IDO
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionIndoleamine 2,3-dioxygenase modulators
TargetsIndoleamine 2,3-dioxygenase
Therapy Area/IndicationsDengue
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumMexico
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRega Institute for Medical Research
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJanssen Pharmaceutica NVUniversidad Nacional Autonoma MexicoRega Institute for Medical Research
Active IndicationsN/A
Inactive IndicationsDengue

Other Information

ATC CodeN/A
Related LinksN/A